LeMaitre Vascular, Inc.

LMATNASDAQHealthcare● Active

$93.72

$-0.76(-0.80%)

Market Cap$2.1B

P/E Ratio—

52W High$118.01

52W Low$79.01

Avg Volume251K

Open$94.63

Beta0.52

Overview

LeMaitre Vascular, Inc.（LMAT）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

lmat · 股价预测 · 20 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 20 位华尔街分析师

Buy

20 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 20 · 买入占比: 70.0%

12 个月目标价

High

$135

Consensus

$128

+34.9% upside

Low

$120

Median: $127.5 · Last Close: $94.55

LeMaitre Vascular, Inc.（LMAT）的分析师共识为 Buy，基于过去 3 个月内 20 位华尔街分析师的评级。LMAT 的 12 个月平均目标价为 $127.50，相对当前价 $94.55 代表 +34.9% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

Historical priceConsensus $128 (34.9%)High $135Low $120

Consensus Target

$127.50

34.9% upside

High Target

$135

42.8%

Low Target

$120

26.9%

Current Price

$94.55

as of today

Based on analyst price targets, the LMAT stock price prediction for the next 12 months ranges from $120 to $135. The consensus LMAT price forecast of $127.50 implies 34.9% upside from the current price of $94.55.

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-09	$92.30	↓ 2.37%	$91.92	$92.68

1-day model range: $91.92–$92.68. Peak: $92.68 (-2.37%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

Year	Low	Avg Price	High	Change
2027	$124	$127	$130	+34.5%
2028	$148	$153	$158	+62.3%
2029	$166	$172	$179	+82.4%
2030	$177	$185	$194	+96.0%
2031	$184	—	$203	+104.7%

Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

29%7%64%

4Buy

1Neutral

9Sell

RSI (14)30.2Neutral

MACDBEARISH

Refreshes daily from EOD close

Moving Averages · LMAT · Jun 8, 2026

Simple Moving Average (SMA)

MA 5$93.17BUY

MA 10$94.09BUY

MA 20$96.78SELL

MA 50$105.59SELL

MA 100$101.05SELL

MA 200$94.44BUY

Current $LMAT · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$93.91BUY

EMA 10$94.71SELL

EMA 20$97.46SELL

EMA 50$101.44SELL

EMA 100$100.26SELL

EMA 200$96.42SELL

Current $LMAT · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2026-06-03	Barrington Research	Maintains	Outperform→Outperform
2026-05-06	Barrington Research	Maintains	Outperform→Outperform
2026-05-06	Wells Fargo	Maintains	Equal Weight→Equal Weight
2026-05-06	Citizens	Maintains	Market Outperform→Market Outperform
2026-02-26	Citizens	Maintains	Market Outperform→Market Outperform
2026-02-26	Barrington Research	Maintains	Outperform→Outperform
2026-02-26	Roth Capital	Maintains	Buy→Buy
2026-02-26	Wells Fargo	Maintains	Equal Weight→Equal Weight
2026-02-20	Barrington Research	Maintains	Outperform→Outperform
2025-11-07	Wells Fargo	Maintains	Equal Weight→Equal Weight

Barrington Research2026-06-03

Maintains

Outperform→Outperform

Barrington Research2026-05-06

Maintains

Outperform→Outperform

Wells Fargo2026-05-06

Maintains

Equal Weight→Equal Weight

Citizens2026-05-06

Maintains

Market Outperform→Market Outperform

Citizens2026-02-26

Maintains

Market Outperform→Market Outperform

Barrington Research2026-02-26

Maintains

Outperform→Outperform

Roth Capital2026-02-26

Maintains

Buy→Buy

Wells Fargo2026-02-26

Maintains

Equal Weight→Equal Weight

Barrington Research2026-02-20

Maintains

Outperform→Outperform

Wells Fargo2025-11-07

Maintains

Equal Weight→Equal Weight

Wall Street analysts have recently issued updated ratings on LeMaitre Vascular, Inc. (LMAT) stock. Of the recent 73 rating actions, 8 were upgrades and 9 were downgrades. 20 analysts currently cover LMAT.

分析师推荐趋势

Buy ratings1 → 1

Hold ratings0 → 0

Sell ratings0 → 0

LMAT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$248M

↓ 18.9% YoY

Revenue Next Year

$280M

↑ 12.9% YoY

EPS This Year

$2.46

EPS Next Year

$3.00

↑ 21.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast LMAT EPS of $2.46 for the current fiscal year, based on estimates from 7 analysts. The LMAT revenue forecast is $248M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

LMAT 股价预测由两类独立数据源支撑：来自 20 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。LMAT 的共识目标价为 $127.50（+34.9% 上行空间），分析师共识为 Buy。

LMAT 的短期预测（明日）为 $92.30（-2.37%）。 LMAT 对 2027 年的股价预测均值为 $127。 LMAT 对 2030 年的预测区间为 $177–$194。

LeMaitre Vascular, Inc. 在 NASDAQ 上市，代码 LMAT。LMAT 在 2027 年的整体展望偏积极，在覆盖分析师中约 70% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

LMAT 预测 · 8 个问题

根据 20 位华尔街分析师，LMAT 的 12 个月平均目标价为 $127.50，最高 $135.00、最低 $120.00。若有图表，中位目标价可在上方查看。相对当前价 $94.55，隐含约 +34.9% 的上行空间。

LMAT 目标价LMAT 分析师目标价LMAT 12个月目标价目标价 LMAT

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.